Cargando…

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family

BACKGROUND: The claudin family is a group of transmembrane proteins related to tight junctions. While their involvement in cancer has been studied extensively, their relationship with the tumor immune microenvironment remains poorly understood. In this research, we focused on genes related to the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Peipei, Peng, Ting, Cao, Canhui, Lin, Shitong, Wu, Ping, Huang, Xiaoyuan, Wei, Juncheng, Xi, Ling, Yang, Qin, Wu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262617/ https://www.ncbi.nlm.nih.gov/pubmed/34249076 http://dx.doi.org/10.3389/fgene.2021.595436

Ejemplares similares

Expression Patterns of Claudin Family Members During Tooth Development and the Role of Claudin-10 (Cldn10) in Cytodifferentiation of Stratum Intermedium
por: Wang, Xin, et al.
Publicado: (2020)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer
por: Rao, XiongHui, et al.
Publicado: (2021)

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
por: Kwon, Mi Jeong, et al.
Publicado: (2010)

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): Compound heterozygous mutation in the claudin 16 (CLDN16) gene
por: Hampson, Geeta, et al.
Publicado: (2008)

CLDN10 is Associated with Papillary Thyroid Cancer Progression
por: Zhou, Yili, et al.
Publicado: (2018)

CLDN1 regulates trophoblast apoptosis and proliferation in preeclampsia
por: Zhang, Yu-chen, et al.
Publicado: (2021)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7)
por: Zhang, Bin, et al.
Publicado: (2020)

Differential Expression of Claudin Family Members during Osteoblast and Osteoclast Differentiation: Cldn-1 Is a Novel Positive Regulator of Osteoblastogenesis
por: Alshbool, Fatima Z., et al.
Publicado: (2014)

The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS
por: Ma, Xinhua, et al.
Publicado: (2020)

Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
por: McDermott, Martina S.J., et al.
Publicado: (2023)

CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer
por: Wang, Canming, et al.
Publicado: (2023)

Mutations in CLDN14 are associated with different hearing thresholds
por: Bashir, Rasheeda, et al.
Publicado: (2010)

Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population
por: OMIDINIA, Eskandar, et al.
Publicado: (2014)

CLDN3 expression and function in pregnancy-induced hypertension
por: Zhao, Aixin, et al.
Publicado: (2020)

The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling
por: Ichikawa-Tomikawa, Naoki, et al.
Publicado: (2023)

A Novel Nonsense Mutation (c.414G>A; p.Trp138*) in CLDN14 Causes Hearing Loss in Yemeni Families: A Case Report
por: Mohamed, Walaa Kamal Eldin, et al.
Publicado: (2019)

CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
por: Gao, Jing, et al.
Publicado: (2023)

A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
por: Deeb, Asma, et al.
Publicado: (2013)

Analysis of the expression and genetic alteration of CLDN18 in gastric cancer
por: Li, Jian, et al.
Publicado: (2020)

Association study of CLDN14 variations in patients with kidney stones
por: Ullah, Ihsan, et al.
Publicado: (2022)

The CLDN5 gene at the blood-brain barrier in health and disease
por: Hashimoto, Yosuke, et al.
Publicado: (2023)

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
por: Hanssen, Oriane, et al.
Publicado: (2014)

Membranous and nuclear staining of CLDN18 in HPV‐independent and HPV‐associated endocervical adenocarcinomas
por: Du, Xiuzhen, et al.
Publicado: (2022)

miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis
por: Kong, Lingchen, et al.
Publicado: (2020)

Genetic and molecular analysis of the CLDN14 gene in Moroccan family with non-syndromic hearing loss
por: Charif, Majida, et al.
Publicado: (2013)

Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis
por: García‐Castaño, Alejandro, et al.
Publicado: (2020)

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival
por: Eftang, Lars L, et al.
Publicado: (2013)

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma
por: Watanabe, Masayuki, et al.
Publicado: (2021)

CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers
por: Qu, Huinan, et al.
Publicado: (2021)

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
por: Lemesle, Marine, et al.
Publicado: (2022)

Molecular dynamics analyses of CLDN15 pore size and charge selectivity
por: McGuinness, Sarah, et al.
Publicado: (2023)

Reply: De novo mutations in CLDN5: alternating hemiplegia of childhood or not?
por: Desguerre, Isabelle, et al.
Publicado: (2023)

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
por: Jia, Keren, et al.
Publicado: (2022)

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
por: Hu, Pan, et al.
Publicado: (2023)

Tight junction CLDN2 gene is a direct target of the vitamin D receptor
por: Zhang, Yong-guo, et al.
Publicado: (2015)

Comment on: “Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors”
por: Li, Cuicui, et al.
Publicado: (2023)

The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance
por: Hou, Yichao, et al.
Publicado: (2020)

CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
por: Yang, Minlan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jc3hu2lq5u4sc0h6pntni1bqh